You are here

Humira

Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita

Forbes

Wed, 02/1/23 - 10:41 am

Amgen launches Humira biosimilar, releases Q4 earnings report

Medical Marketing and Media

Tue, 01/31/23 - 11:21 pm

Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug

BioPharma Dive

Tue, 01/31/23 - 12:37 pm

The end of the Humira era

EP Vantage

Mon, 01/30/23 - 10:46 am

AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.

Motley Fool

Sun, 01/22/23 - 01:01 pm

Amgen prepped to take first slice of AbbVie’s US Humira pie

BioProcess International

Wed, 01/18/23 - 11:00 pm

Looking past Humira, AbbVie boosts sales forecasts for successor drugs

BioPharma Dive

Wed, 01/11/23 - 12:22 pm

Richard Gonzalez

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars

Drug Channels

Tue, 01/10/23 - 10:44 am

Express Scripts

Optum to add biosimilars to formulary to tackle the massive cost of Humira

Fierce Healthcare

Wed, 11/16/22 - 11:16 pm

AbbVie Drops Autoimmune Candidate, Prioritizes Skyrizi and Rinvoq

BioSpace

Tue, 11/1/22 - 11:04 am

AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now

Endpoints

Sun, 10/30/22 - 04:22 pm

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

Drug Channels

Fri, 10/14/22 - 10:15 am

Where Will AbbVie Be in 3 Years?

Motley Fool

Fri, 09/30/22 - 10:50 am

Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?

Fierce Pharma

Tue, 09/13/22 - 08:03 pm

hidradenitis suppurativa

FDA holds back Alvotech’s Humira biosimilar over manufacturing issues

BioPharma Dive

Tue, 09/6/22 - 04:57 pm

drug manufacturing

'What’s wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case

Endpoints

Tue, 08/2/22 - 11:22 pm

In last Q2 with Humira market lock, AbbVie leans on best-seller to offset Imbruvica losses

Fierce Pharma

Mon, 08/1/22 - 10:35 am

FDA reviewing higher dose Hyrimoz biosimilar

Biopharma Reporter

Fri, 07/22/22 - 11:14 am

As biosimilars gain steam, Amgen exec lays out its Humira copycat plans

Fierce Pharma

Wed, 06/22/22 - 06:57 pm

More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy

Fierce Pharma

Mon, 06/20/22 - 10:37 am

autoimmune disease

Pages